Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
about
Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissueGenetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and SurvivalStem cells as cellular vehicles for gene therapy against glioblastomaHow to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic CardiomyopathyChemokine contribution in stem cell engraftment into the infarcted myocardiumMesenchymal stem cell secretome and regenerative therapy after cancerEngineering mesenchymal stem cells for regenerative medicine and drug deliveryAdenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantationPulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapyNoninvasive pulsed focused ultrasound allows spatiotemporal control of targeted homing for multiple stem cell types in murine skeletal muscle and the magnitude of cell homing can be increased through repeated applications.Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseMimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions.mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapyTLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissuesActin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivoMicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytesSpecific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.Genetic engineering of mesenchymal stem cells and its application in human disease therapy.Mesenchymal stem cells as therapeutics and vehicles for gene and drug deliverySafe genetic modification of cardiac stem cells using a site-specific integration technique.Paracrine mechanisms of stem cell reparative and regenerative actions in the heartMesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyondAgonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.Mesenchymal stem cells at the intersection of cell and gene therapy.Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits.Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction.The effects of harvesting media on biological characteristics and repair potential of neural stem cells after traumatic brain injury.Loss of Gata5 in mice leads to bicuspid aortic valve.Prostaglandin E₁ protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosisHarnessing the mesenchymal stem cell secretome for the treatment of cardiovascular diseaseEffect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss.Sensing the cardiac environment: exploiting cues for regenerationAssessment of the green florescence protein labeling method for tracking implanted mesenchymal stem cells.Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium.
P2860
Q21133511-0CD59011-2038-44BB-AAB7-9AFB19BE5E90Q26744561-1966EB3E-4F1F-44AB-A768-6DB0CB9403F4Q26771835-DA995B8F-2E7D-46A4-A2C6-566CCAAB8EFAQ26774939-F13FA8C3-F819-4B68-8C66-2FDD48976884Q26796004-59D549D0-C7B4-48C2-A9B0-BE067A0E532DQ26863520-7E5DABCA-B780-42AE-B25B-FFE7B0EFC5BEQ27007499-3C292AA3-B9C7-4FA2-B011-5717F176098FQ27026414-CC2C025A-047A-4F2A-A82C-51473B986A13Q27324639-89BC3CA8-2030-41DC-8159-005E90636FFEQ27329535-B5722568-3A3E-4BFE-86CC-B8EC73BBA1BAQ28082334-D14926F7-2552-445C-985F-E1B6EB089D4AQ30427305-0D22AAD8-E92A-4EB3-AA83-22849A7DABCBQ30449821-6B5A71BD-D0DE-4500-B7FA-AE6ABAFEC0F8Q30503541-86B349C5-4E91-437E-9AD3-A57A24B88979Q30548207-513201D7-3ADA-4C9A-9D25-C049E7DD2AF8Q30601810-141E309F-D8AE-45D4-9E92-6612B7011F11Q30690412-EDFB947D-615A-4B65-8B98-3A4F77E09B6FQ33696606-6C0EC52F-E05A-4058-AB12-4F0E61C3764AQ33769592-D45F8A36-7A91-4B7A-BD0A-8CBCFDE596FAQ33911166-1102CA65-E6B8-4151-8EC2-5E9436285144Q33949125-329E65FC-BE93-4AEE-9817-04C83A0DA923Q34031669-146BDF78-5000-416F-9E05-067FB402F516Q34062891-4C90011D-30D9-4A05-9FD8-462A46C5AC2BQ34298871-826C867C-48E5-4EC9-83AB-A8947E759DF0Q34349428-9C1DF134-4D80-4B65-A044-554319241000Q34410872-3CB380A4-F870-4527-8C2B-31BCE9CDD917Q34494230-4E96B46D-F7BC-4A83-92DD-5D8B5E649198Q34635689-BD3F356E-8405-43D8-9CF4-B5EF54D0DD1AQ34661275-0EB1C93E-69DD-44D9-A44C-FA19F9142BB1Q34676808-12D6E8A7-2337-479B-9663-796D4BA00BC3Q34713207-49727D94-D759-4D45-9E4E-E4F44439E63EQ35037360-69CAD546-9605-465E-B786-042A5888355FQ35270936-2C1D2CF6-DDFA-4B4D-A570-3CF82AD0023BQ35572391-F78B72D4-B5BA-46E3-82CC-E775887DB46FQ35739823-C816053B-A6BF-4085-9A07-B48EF32DFEC2Q35804026-5EA99908-8A35-4619-AA09-C82F6A04023FQ35844020-799CDF4B-E309-4CD5-8C3D-C5C12732C98BQ35906866-151004A0-CF3F-45AD-8552-517EC4135ACEQ36095554-45590417-854C-42BC-8FC1-4B4CA3ED85D2Q36401882-8A2512F2-E10E-4ECD-9219-7EA00AE514E1
P2860
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic modification of mesenc ...... ity in the injured myocardium.
@ast
Genetic modification of mesenc ...... ity in the injured myocardium.
@en
type
label
Genetic modification of mesenc ...... ity in the injured myocardium.
@ast
Genetic modification of mesenc ...... ity in the injured myocardium.
@en
prefLabel
Genetic modification of mesenc ...... ity in the injured myocardium.
@ast
Genetic modification of mesenc ...... ity in the injured myocardium.
@en
P2093
P2860
P1433
P1476
Genetic modification of mesenc ...... ity in the injured myocardium.
@en
P2093
Jing Huang
Lunan Zhang
Maria Mirotsou
Richard E Pratt
Victor J Dzau
Zhiping Zhang
P2860
P304
P356
10.1161/CIRCRESAHA.109.196030
P577
2010-04-08T00:00:00Z